drugset / Trial / NCT04621669
Drug-durg Interaction of SHR3680 With Digoxin, Rosuvastatin Calcium and Metformin Hydrochloride
RandomizedParallel-groupOpen-labelTreatment
Summary
The DDI study had been designed to investigate the effect of SHR3680 on the pharmacokinetics of digoxin, Rosuvastatin calcium and metformin hydrochloride.
Timeline
- Start
- 2021-01-08
- Primary completion
- 2021-09-08
- Completion
- 2021-09-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Digoxin | Other / unclassified | 0.25 mg | — |
| Subject | Metformin | Small molecule | 500 mg | — |
| Subject | Rezvilutamide | Small molecule | 240 mg | — |
| Subject | Rosuvastatin | Small molecule | 10 mg | — |
Indications
No indication recorded.